Science · Open for opinions
Will the FDA formally announce regulatory progress on LSD for the treatment of anxiety by October 31, 2026?
With LSD approval projections for anxiety in the US by 2027, the market awaits initial regulatory milestones (considering… 37 opinions, 65% No
- Yes — 35%
- No — 65%
Deadline: October 31, 2026 at 11:59 PM UTC · 37 opinions
Resolution rules
With LSD approval projections for anxiety in the US by 2027, the market awaits initial regulatory milestones (considering announcements between 09/16 and 10/31).
Source: www.newscientist.com
Frequently asked questions about this event
How is this event resolved?
Janela de apuração: de 16/09/2026 (00:00, horário de Brasília) até 31/10/2026 (23:59). Resolve como 'Sim' se a agência americana FDA publicar em seus canais oficiais (fda.gov) a concessão de 'Breakthrough Therapy' ou a aceitação de pedido de registro para uso terapêutico de LSD na ansiedade até 31/10/2026. Confirmação do laboratório patrocinador por meio de fato relevante oficial também é válida. Caso contrário, resolve como 'Não'.
How are points scored?
Points depend on the share of votes your side had when you gave your opinion. Being right earns 100 minus that share. Being wrong costs that share.
Right now No has 65% of the votes: an opinion on it that turns out right earns about 35 points, a wrong one costs about 65.